top of page

Browse by category

Search

GLP-1 receptor agonists target fat over muscle for weight loss

GLP-1 receptor agonists target fat over muscle for weight loss

A research team from the School of Public Health, in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), who assessed...

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...

Poor muscle health common in people living with obesity increases early mortality risk

Poor muscle health common in people living with obesity increases early mortality risk

Poor muscle health is associated with a higher risk of an early death in people living with obesity and individuals with adverse muscle...

BELIEVE study to assess Bimagrumab as treatment for obesity

BELIEVE study to assess Bimagrumab as treatment for obesity

Versanis Bio, a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, has announced that...

More than 65 organisations advocate for coverage of obesity care in open letter to leading employers as Obesity Care Week urges expanded coverage to include FDA-approved obesity medications

3 days ago

Naturally occurring BRP molecule rivals semaglutide in weight loss but without side effects

3 days ago

Melatonin improves muscle energy efficiency offering a potential therapy to combat diabesity

4 days ago

Back to Top

bottom of page